Search results
Results from the WOW.Com Content Network
Guillain–Barré syndrome (also called "GBS") is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system. [3] Typically, both sides of the body are involved, and the initial symptoms are changes in sensation or pain often in the back along with muscle weakness, beginning in the feet and hands, often spreading to the arms and upper body. [3]
Children less than 5 years old with a history of recurrent wheezing [17] Children or adolescents receiving aspirin [17] People with a history of Guillain–Barré syndrome, a rare disorder of the nervous system [17] Pregnant women [17] People who have a severe allergy to chicken eggs or who are allergic to any of the nasal spray vaccine ...
Guillain-Barré syndrome (pronounced gee-YAH-buh-RAY) is a rare autoimmune disorder that has been getting attention recently because of its potential connection with the coronavirus. In a letter ...
The drug or other substance has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use of the drug or other substance under medical supervision. The complete list of Schedule I substances is as follows. [1] The Administrative Controlled Substances Code Number for each substance is included.
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently [1] accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The drug, ANX005, was tested in 241 patients with GBS and met the main goal of the study. Annexon has begun another trial to confirm the results in U.S. patients. Annexon's neurological disease ...
The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV. The drug or other substance has a currently accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or ...
This is the list of Schedule IV controlled substances in the United States as defined by the Controlled Substances Act. [1] The following findings are required for substances to be placed in this schedule: [2] The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule III.